Medical mycology and toxicology

(i) Molecular diagnostics, epidemiology, phylogeny, detection strategies, and drug resistance in/of emerging opportunistic, human-pathogenic fungi (Scedosporium/Pseudallescheria complex); diversity and frequency of yeasts in the lower respiratory tract of TICU patients; (ii) indoor moulds, allergies and Sick Building Syndrome; (iii) diagnoses of mu shroom intoxications, detection of toxins in clinical material (e.g., orellanine in biopsy specimens), design and development of new detection methods.